National Library of Medicine Citations for Allergic Rhinitis (Hay Fever)

The following have had published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

Some studies were done on people with specific conditions, ethnic origin or diet style (i.e. traditional Chinese Diet versus Western Diet), which may be why some shifts are in opposite directions.

See this post about overlapping bacteria/taxa and possible progression of conditions.

AI Engines For more Details: Perplexity  Kagi Labs  You 

Note these are associations and not causation. Items being high or low may be part of the immune response.

You do not have any samples under this email

A percentile below 20% can be deemed to be low, and above 80% as high. These are arbitrary values.

Tax Rank Tax Name Shift Percentile Distribution Citation Link
class Actinomycetia (NCBI:1760 ) Low Distribution    📚 PubMed
family Porphyromonadaceae (NCBI:171551 ) Low Distribution    📚 PubMed
family Ruminococcaceae (NCBI:541000 ) High Distribution    📚 PubMed
genus Bacteroides (NCBI:816 ) High Distribution    📚 PubMed
genus Bifidobacterium (NCBI:1678 ) Low Distribution    📚 PubMed
genus Bifidobacterium (NCBI:1678 ) Low Distribution    📚 PubMed
genus Clostridium (NCBI:1485 ) High Distribution    📚 PubMed
genus Enterobacter (NCBI:547 ) High Distribution    📚 PubMed
genus Enterococcus (NCBI:1350 ) High Distribution    📚 PubMed
genus Escherichia (NCBI:561 ) High Distribution    📚 PubMed
genus Lactobacillus (NCBI:1578 ) Low Distribution    📚 PubMed
genus Parabacteroides (NCBI:375288 ) High Distribution    📚 PubMed
genus Prevotella (NCBI:838 ) High Distribution    📚 PubMed
genus Pyramidobacter (NCBI:638847 ) High Distribution    📚 PubMed
order Bacteroidales (NCBI:171549 ) High Distribution    📚 PubMed
phylum Actinobacteria (NCBI:201174 ) Low Distribution    📚 PubMed
phylum Proteobacteria (NCBI:1224 ) Low Distribution    📚 PubMed
species [Clostridium] hylemonae (NCBI:89153 ) High Distribution    📚 PubMed
species Acetivibrio straminisolvens (NCBI:253314 ) Low Distribution    📚 PubMed
species Acidaminococcus intestini (NCBI:187327 ) High Distribution    📚 PubMed
species Agathobaculum butyriciproducens (NCBI:1628085 ) Low Distribution    📚 PubMed
species Anaerotruncus colihominis (NCBI:169435 ) High Distribution    📚 PubMed
species Bifidobacterium adolescentis (NCBI:1680 ) Low Distribution    📚 PubMed
species Bifidobacterium catenulatum (NCBI:1686 ) Low Distribution    📚 PubMed
species Bifidobacterium longum (NCBI:216816 ) Low Distribution    📚 PubMed
species Clostridium butyricum (NCBI:1492 ) Low Distribution    📚 PubMed
species Coprococcus eutactus (NCBI:33043 ) Low Distribution    📚 PubMed
species Dialister succinatiphilus (NCBI:487173 ) Low Distribution    📚 PubMed
species Enterocloster asparagiformis (NCBI:333367 ) Low Distribution    📚 PubMed
species Eubacterium xylanophilum (NCBI:39497 ) Low Distribution    📚 PubMed
species Intestinimonas butyriciproducens (NCBI:1297617 ) Low Distribution    📚 PubMed
species Muricomes intestini (NCBI:1796634 ) Low Distribution    📚 PubMed
species Murimonas intestini (NCBI:1337051 ) Low Distribution    📚 PubMed
species Oscillibacter valericigenes (NCBI:351091 ) Low Distribution    📚 PubMed
species Oxalobacter formigenes (NCBI:847 ) Low Distribution    📚 PubMed
species Phocaeicola massiliensis (NCBI:204516 ) Low Distribution    📚 PubMed
species Rothia mucilaginosa (NCBI:43675 ) Low Distribution    📚 PubMed
species Ruminiclostridium papyrosolvens (NCBI:29362 ) Low Distribution    📚 PubMed
species Ruminococcus gnavus (NCBI:33038 ) High Distribution    📚 PubMed
species Sutterella wadsworthensis (NCBI:40545 ) Low Distribution    📚 PubMed

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)